The role of PCMT1 in prognosis tumor immune microenvironment and therapeutic responses across cancers
Abstract Background Emerging evidence highlights the overexpression of Protein-L-isoaspartate (D-aspartate) O-methyltransferase (PCMT1) in multiple malignancies. However, its pan-cancer prognostic significance, tumor immune microenvironment (TIME) interactions, and therapeutic implications remain un...
Gorde:
| Egile Nagusiak: | , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer
2026-01-01
|
| Saila: | Discover Oncology |
| Gaiak: | |
| Sarrera elektronikoa: | https://doi.org/10.1007/s12672-025-04366-2 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|